Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway
Drug Design, Development and Therapy · 2025-04 · Volume 19 · 2491-2502
DOI: 10.2147/dddt.s485240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-04. Verfasst von Xinxing Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospita…. Hauptthemen laut MEDLINE: Lactones, Ginkgolides, TOR Serine-Threonine Kinases, Stomach Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
- Beijing Shijitan Hospital, Capital Medical University, Beijing, People's Republic of China.
ORCID-Profile: Ziyu Li
Zitieren
APA
Lu, X., Zhang, Y., Wang, R., & Li, Z. (2025). Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway. Drug Design, Development and Therapy, Volume 19, 2491-2502. https://doi.org/10.2147/dddt.s485240
Vancouver
Lu X, Zhang Y, Wang R, Li Z. Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway. Drug Design, Development and Therapy. 2025;Volume 19:2491-2502. doi:10.2147/dddt.s485240
BibTeX
@article{Lu2025,
author = {Lu, Xinxing and Zhang, Yan and Wang, Ran and Li, Ziyu},
title = {Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {2491--2502},
doi = {10.2147/dddt.s485240}
}
EUVIMED